Related Experiment Videos

Reply to S. Barni et Al and M. Sun et Al

Bernard Escudier¹, Camillo Porta², Thomas Powles³

¹Institut Gustave Roussy, Villejuif, France escudier@igr.fr.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|October 1, 2014

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET.

European journal of cancer (Oxford, England : 1990)·2026

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Nature medicine·2026

Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.

European urology·2025

High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi study.

European journal of cancer (Oxford, England : 1990)·2025

Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT).

European journal of cancer (Oxford, England : 1990)·2025

See all related articles